Literature DB >> 19482438

Association of genes coding for the alpha-4, alpha-5, beta-2 and beta-3 subunits of nicotinic receptors with cigarette smoking and nicotine dependence.

Jean-François Etter1, Jean-Charles Hoda, Nader Perroud, Marcus Munafò, Catherine Buresi, Claudette Duret, Elisabeth Neidhart, Alain Malafosse, Daniel Bertrand.   

Abstract

We assessed whether smoking behavior was associated with nine polymorphisms in genes coding for the nicotinic receptor subunits alpha-4 (rs1044394, rs1044396, rs2236196 and rs2273504), alpha-5 (rs16969968), beta-2 (rs2072661 and rs4845378) and beta-3 (rs4953 and rs6474413).We conducted an Internet survey and collected saliva by mail for DNA and cotinine analyses, in Switzerland in 2003. We conducted DNA analyses for 277 participants and cotinine analyses for 141 current daily smokers. Cotinine levels were higher in carriers of the CC genotype of CHRNA4 rs1044396 (371 ng/ml) than in those with the CT or TT genotypes (275 ng/ml, p=0.049), a difference of 0.53 standard deviation units. However, this difference was not robust to correction for multiple testing using Bonferroni adjustment. These 9 polymorphisms were not otherwise associated with smoking behavior and nicotine dependence. There were possible associations between the temperament trait novelty seeking and CHRNA4 rs1044396, CHRNA5 rs16969968 and CHRNB2 rs4845378, but these associations were not robust to correction for multiple testing. We conclude that the analysis of polymorphisms in genes coding for four nicotinic acetylcholine receptor subunits (CHRNA4, CHRNA5, CHRNB2 and CHRNB3) and several smoking-related phenotypes revealed no statistically significant association.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19482438     DOI: 10.1016/j.addbeh.2009.05.010

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  20 in total

1.  CHRNB2 promoter region: association with subjective effects to nicotine and gene expression differences.

Authors:  N R Hoft; J A Stitzel; K E Hutchison; M A Ehringer
Journal:  Genes Brain Behav       Date:  2010-11-04       Impact factor: 3.449

2.  Nominal association with CHRNA4 variants and nicotine dependence.

Authors:  H M Kamens; R P Corley; M B McQueen; M C Stallings; C J Hopfer; T J Crowley; S A Brown; J K Hewitt; M A Ehringer
Journal:  Genes Brain Behav       Date:  2013-02-06       Impact factor: 3.449

3.  Association of CHRNA4 polymorphisms with smoking behavior in two populations.

Authors:  Shizhong Han; Bao-Zhu Yang; Henry R Kranzler; David Oslin; Raymond Anton; Joel Gelernter
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-03-28       Impact factor: 3.568

4.  Chromosome 20 shows linkage with DSM-IV nicotine dependence in Finnish adult smokers.

Authors:  Kaisu Keskitalo-Vuokko; Jenni Hällfors; Ulla Broms; Michele L Pergadia; Scott F Saccone; Anu Loukola; Pamela A F Madden; Jaakko Kaprio
Journal:  Nicotine Tob Res       Date:  2011-10-29       Impact factor: 4.244

5.  Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence.

Authors:  Riju Ray; Nandita Mitra; Don Baldwin; Mengye Guo; Freda Patterson; Daniel F Heitjan; Christopher Jepson; E Paul Wileyto; Jinxue Wei; Thomas Payne; Jennie Z Ma; Ming D Li; Caryn Lerman
Journal:  Neuropsychopharmacology       Date:  2010-02-10       Impact factor: 7.853

6.  Resequencing of nicotinic acetylcholine receptor genes and association of common and rare variants with the Fagerström test for nicotine dependence.

Authors:  Jennifer Wessel; Sarah M McDonald; David A Hinds; Renee P Stokowski; Harold S Javitz; Michael Kennemer; Ruth Krasnow; William Dirks; Jill Hardin; Steven J Pitts; Martha Michel; Lisa Jack; Dennis G Ballinger; Jennifer B McClure; Gary E Swan; Andrew W Bergen
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

Review 7.  Pharmacogenetics of new analgesics.

Authors:  Jörn Lötsch; Gerd Geisslinger
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

8.  Assessing the impact of nicotine dependence genes on the risk of facial clefts: An example of the use of national registry and biobank data.

Authors:  Astanand Jugessur; Allen J Wilcox; Jeffrey C Murray; Håkon K Gjessing; Truc Trung Nguyen; Roy M Nilsen; Rolv T Lie
Journal:  Nor Epidemiol       Date:  2012

Review 9.  Linking the CHRNA5 SNP to drug abuse liability: From circuitry to cellular mechanisms.

Authors:  Julia K Brynildsen; Julie A Blendy
Journal:  Neuropharmacology       Date:  2021-02-01       Impact factor: 5.250

10.  Distinct loci in the CHRNA5/CHRNA3/CHRNB4 gene cluster are associated with onset of regular smoking.

Authors:  Sarah H Stephens; Sarah M Hartz; Nicole R Hoft; Nancy L Saccone; Robin C Corley; John K Hewitt; Christian J Hopfer; Naomi Breslau; Hilary Coon; Xiangning Chen; Francesca Ducci; Nicole Dueker; Nora Franceschini; Josef Frank; Younghun Han; Nadia N Hansel; Chenhui Jiang; Tellervo Korhonen; Penelope A Lind; Jason Liu; Leo-Pekka Lyytikäinen; Martha Michel; John R Shaffer; Susan E Short; Juzhong Sun; Alexander Teumer; John R Thompson; Nicole Vogelzangs; Jacqueline M Vink; Angela Wenzlaff; William Wheeler; Bao-Zhu Yang; Steven H Aggen; Anthony J Balmforth; Sebastian E Baumeister; Terri H Beaty; Daniel J Benjamin; Andrew W Bergen; Ulla Broms; David Cesarini; Nilanjan Chatterjee; Jingchun Chen; Yu-Ching Cheng; Sven Cichon; David Couper; Francesco Cucca; Danielle Dick; Tatiana Foroud; Helena Furberg; Ina Giegling; Nathan A Gillespie; Fangyi Gu; Alistair S Hall; Jenni Hällfors; Shizhong Han; Annette M Hartmann; Kauko Heikkilä; Ian B Hickie; Jouke Jan Hottenga; Pekka Jousilahti; Marika Kaakinen; Mika Kähönen; Philipp D Koellinger; Stephen Kittner; Bettina Konte; Maria-Teresa Landi; Tiina Laatikainen; Mark Leppert; Steven M Levy; Rasika A Mathias; Daniel W McNeil; Sarah E Medland; Grant W Montgomery; Tanda Murray; Matthias Nauck; Kari E North; Peter D Paré; Michele Pergadia; Ingo Ruczinski; Veikko Salomaa; Jorma Viikari; Gonneke Willemsen; Kathleen C Barnes; Eric Boerwinkle; Dorret I Boomsma; Neil Caporaso; Howard J Edenberg; Clyde Francks; Joel Gelernter; Hans Jörgen Grabe; Hyman Hops; Marjo-Riitta Jarvelin; Magnus Johannesson; Kenneth S Kendler; Terho Lehtimäki; Patrik K E Magnusson; Mary L Marazita; Jonathan Marchini; Braxton D Mitchell; Markus M Nöthen; Brenda W Penninx; Olli Raitakari; Marcella Rietschel; Dan Rujescu; Nilesh J Samani; Ann G Schwartz; Sanjay Shete; Margaret Spitz; Gary E Swan; Henry Völzke; Juha Veijola; Qingyi Wei; Chris Amos; Dale S Cannon; Richard Grucza; Dorothy Hatsukami; Andrew Heath; Eric O Johnson; Jaakko Kaprio; Pamela Madden; Nicholas G Martin; Victoria L Stevens; Robert B Weiss; Peter Kraft; Laura J Bierut; Marissa A Ehringer
Journal:  Genet Epidemiol       Date:  2013-11-01       Impact factor: 2.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.